Cisplatin Accord Healthcare 1 mg/ml concentraat voor oplossing voor infusie

DRUG3 trials

Sponsors

Antwerp University Hospital, Universitair Medisch Centrum Groningen, Universitair Medisch Centrum Utrecht

Conditions

Locally advanced head and neck squamous cell carcinomaVulvar cancerinoperable pleural mesothelioma

Phase 2

GROINSS-V III; Groningen International Study on Sentinel node in Vulvar cancer III – a prospective phase 2 treatment trial

RecruitingCTIS2023-508722-99-00

Universitair Medisch Centrum GroningenVulvar cancer

Start: 2020-11-19Target: 92Updated: 2025-04-14

NEoadjuvant Chemotherapy and Immunotherapy for a selected group of inoperable pleural Mesothelioma patients (NECIM): a feasibility study

RecruitingCTIS2023-504302-11-02

Antwerp University Hospitalinoperable pleural mesothelioma

Start: 2025-07-22Target: 37Updated: 2025-11-21

Phase 4

Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiation in sarcopenic patients with head and neck squamous cell carcinoma

Active, not recruitingCTIS2024-514919-10-00

Universitair Medisch Centrum UtrechtLocally advanced head and neck squamous cell carcinoma

Start: 2022-01-24Target: 160Updated: 2024-11-11